Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Wave Life Sciences ( (WVE) ) is now available.
On December 9, 2025, Wave Life Sciences announced an underwritten public offering of 15,789,475 ordinary shares at $19.00 per share and pre-funded warrants for 2,631,578 shares at $18.9999 each, expecting gross proceeds of approximately $402.5 million. The offering, which includes an option for underwriters to purchase additional shares, is anticipated to close on December 11, 2025, and will support the company’s operations into the third quarter of 2028, enhancing its market positioning and financial stability.
The most recent analyst rating on (WVE) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Wave Life Sciences stock, see the WVE Stock Forecast page.
Spark’s Take on WVE Stock
According to Spark, TipRanks’ AI Analyst, WVE is a Neutral.
Wave Life Sciences’ stock score is primarily driven by strong technical momentum and positive earnings call sentiment, indicating potential growth opportunities. However, significant financial performance challenges and poor valuation metrics present substantial risks, resulting in a moderate overall score.
To see Spark’s full report on WVE stock, click here.
More about Wave Life Sciences
Wave Life Sciences is a biotechnology company focused on developing RNA medicines to transform human health. The company utilizes its PRISM® platform to deliver RNA-targeting modalities, including editing, splicing, RNA interference, and antisense silencing, to treat both rare and common disorders. Its pipeline includes clinical programs for conditions such as obesity, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, and Huntington’s disease.
Average Trading Volume: 5,706,854
Technical Sentiment Signal: Buy
Current Market Cap: $3.56B
See more data about WVE stock on TipRanks’ Stock Analysis page.